In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect J Andreani, M Le Bideau, I Duflot, P Jardot, C Rolland, M Boxberger, ... Microbial pathogenesis 145, 104228, 2020 | 359 | 2020 |
Correlation between 3790 quantitative polymerase chain reaction–positives samples and positive cell cultures, including 1941 severe acute respiratory syndrome coronavirus 2 … R Jaafar, S Aherfi, N Wurtz, C Grimaldier, T Van Hoang, P Colson, ... Clinical Infectious Diseases 72 (11), e921-e921, 2021 | 221 | 2021 |
Pfhrp2 and pfhrp3 polymorphisms in Plasmodium falciparum isolates from Dakar, Senegal: impact on rapid malaria diagnostic tests N Wurtz, B Fall, K Bui, A Pascual, M Fall, C Camara, B Diatta, KB Fall, ... Malaria journal 12, 1-8, 2013 | 163 | 2013 |
Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories N Wurtz, A Papa, M Hukic, A Di Caro, I Leparc-Goffart, E Leroy, ... European Journal of Clinical Microbiology & Infectious Diseases 35, 1247-1258, 2016 | 140 | 2016 |
Vivax malaria in Mauritania includes infection of a Duffy-negative individual N Wurtz, K Mint Lekweiry, H Bogreau, B Pradines, C Rogier, ... Malaria journal 10, 1-8, 2011 | 137 | 2011 |
Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs B Pastorino, A Nougairède, N Wurtz, E Gould, X De Lamballerie Antiviral research 87 (3), 281-294, 2010 | 124 | 2010 |
Culture of SARS-CoV-2 in a panel of laboratory cell lines, permissivity, and differences in growth profile N Wurtz, G Penant, P Jardot, N Duclos, B La Scola European Journal of Clinical Microbiology & Infectious Diseases 40 (3), 477-484, 2021 | 101 | 2021 |
Plasmodium falciparum proteome changes in response to doxycycline treatment S Briolant, L Almeras, M Belghazi, E Boucomont-Chapeaublanc, N Wurtz, ... Malaria journal 9, 1-14, 2010 | 93 | 2010 |
Role of Pfmdr1 in In Vitro Plasmodium falciparum Susceptibility to Chloroquine, Quinine, Monodesethylamodiaquine, Mefloquine, Lumefantrine, and … N Wurtz, B Fall, A Pascual, M Fall, E Baret, C Camara, A Nakoulima, ... Antimicrobial agents and chemotherapy 58 (12), 7032-7040, 2014 | 83 | 2014 |
Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal N Wurtz, B Fall, A Pascual, S Diawara, K Sow, E Baret, B Diatta, KB Fall, ... Malaria journal 11, 1-10, 2012 | 58 | 2012 |
Molecular surveillance of drug-resistant Plasmodium vivax using pvdhfr, pvdhps and pvmdr1 markers in Nouakchott, Mauritania K Mint Lekweiry, A Ould Mohamed Salem Boukhary, T Gaillard, N Wurtz, ... Journal of antimicrobial chemotherapy 67 (2), 367-374, 2012 | 56 | 2012 |
Susceptibility of Plasmodium falciparum Isolates to Doxycycline Is Associated with pftetQ Sequence Polymorphisms and pftetQ and pfmdt Copy Numbers S Briolant, N Wurtz, A Zettor, C Rogier, B Pradines The Journal of infectious diseases 201 (1), 153-159, 2010 | 54 | 2010 |
Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum V Parquet, M Henry, N Wurtz, J Dormoi, S Briolant, M Gil, E Baret, ... Malaria Journal 9, 1-7, 2010 | 37 | 2010 |
Choosing a cellular model to study SARS-CoV-2 GA Pires De Souza, M Le Bideau, C Boschi, N Wurtz, P Colson, S Aherfi, ... Frontiers in cellular and infection microbiology 12, 1003608, 2022 | 36 | 2022 |
Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study B Fall, A Pascual, FD Sarr, N Wurtz, V Richard, E Baret, Y Diémé, ... Malaria Journal 12, 1-11, 2013 | 33 | 2013 |
Monitoring the circulation of SARS-CoV-2 variants by genomic analysis of wastewater in Marseille, South-East France N Wurtz, O Revol, P Jardot, A Giraud-Gatineau, L Houhamdi, ... Pathogens 10 (8), 1042, 2021 | 29 | 2021 |
cAMP-dependent protein kinase from Plasmodium falciparum: an update N Wurtz, C Chapus, J Desplans, D Parzy Parasitology 138 (1), 1-25, 2011 | 29 | 2011 |
Viral RNA in city wastewater as a key indicator of COVID-19 recrudescence and containment measures effectiveness N Wurtz, A Lacoste, P Jardot, A Delache, X Fontaine, M Verlande, ... Frontiers in microbiology 12, 664477, 2021 | 27 | 2021 |
Emergence of Plasmodium ovale Malaria Among the French Armed Forces in the Republic of Ivory Coast: 20 Years of Clinical and Biological Experience F De Laval, F Simon, H Bogreau, C Rapp, N Wurtz, M Oliver, X Demaison, ... Clinical Infectious Diseases 58 (8), e122-e128, 2014 | 27 | 2014 |
Negative impact of laws regarding biosecurity and bioterrorism on real diseases N Wurtz, MP Grobusch, D Raoult Clinical Microbiology and Infection 20 (6), 507-515, 2014 | 24 | 2014 |